PFE - Pfizer: A Post Spinoff Dividend Growth Opportunity
Pfizer (PFE) is a major international pharmaceutical company that is currently in the process of transitioning its core business. In the late 2000s, Pfizer made numerous acquisitions, which have resulted in the company experiencing multiple restructuring costs, cutting their dividend in 2008, and experiencing relatively low increases in key financial metrics over the last decade. However, the company's current strategy to split off its generic Upjohn business and focus on its key biopharmaceutical group represents an opportunity for Pfizer to provide some strong growth going forward. This new consolidated Pfizer following the split-off